Literature DB >> 10784303

Eye care for the critically ill.

P Suresh1, F Mercieca, A Morton, A B Tullo.   

Abstract

PURPOSE: To evaluate the effectiveness and efficiency of an algorithm in the prevention of ocular surface disease in sedated and unconscious patients in the intensive care unit (ICU).
METHODS: The eyes of all sedated and unconscious patients admitted to an ICU between September and December 1998 were managed according to an eye care algorithm. The applications of the preventive measures were assessed by a single observer twice weekly. The lid position, the presence and degree of keratopathy, sedation score, and the treatment received were documented at every assessment.
RESULTS: Thirty-four patients were recruited for management according to the eye care algorithm over a period ranging from 1 to 28 days. Four patients were excluded because of failure by staff to adhere to the protocol. In 18 patients no active treatment was required. Out of six patients who had conjunctival exposure and were given ocular lubricants, four maintained clear corneas. No corneal or conjunctival staining was noted in two of the four patients whose lids required closure with Micropore tape for corneal exposure. Use of lid taping and lubricants prevented corneal abrasion in two patients who were prone ventilated. The prevalence of ocular surface abnormalities was 8.7 % where the algorithm was properly followed (23 patients).
CONCLUSION: The proposed eye care algorithm appears to be effective in preventing ocular surface abnormalities in the sedated and unconscious patients in the ICU, and efficient in that it may reduce the workload required for critically ill patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10784303     DOI: 10.1007/s001340050040

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

1.  Endogenous endophthalmitis.

Authors:  A P Betrosian; E Kolomtsas; M Balla; M Papanikolaou; G Labroulis; G Georgiadis
Journal:  Intensive Care Med       Date:  2000-11       Impact factor: 17.440

2.  Eye care in the intensive care unit.

Authors:  Benjamin J Hearne; Elewys G Hearne; Hugh Montgomery; Susan L Lightman
Journal:  J Intensive Care Soc       Date:  2018-03-22

Review 3.  Is ophthalmology evidence based? A clinical audit of the emergency unit of a regional eye hospital.

Authors:  T Y Y Lai; V W Y Wong; G M Leung
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

4.  A randomised controlled study of the efficacy of hypromellose and Lacri-Lube combination versus polyethylene/Cling wrap to prevent corneal epithelial breakdown in the semiconscious intensive care patient.

Authors:  Natasha Koroloff; Robert Boots; Jeff Lipman; Peter Thomas; Claire Rickard; Fiona Coyer
Journal:  Intensive Care Med       Date:  2004-03-10       Impact factor: 17.440

5.  Different Nursing Care Methods for Prevention of Keratopathy Among Intensive Care Unit Patients.

Authors:  Reza Pourmirza Kalhori; Sohrab Ehsani; Farid Daneshgar; Hossein Ashtarian; Mansour Rezaei
Journal:  Glob J Health Sci       Date:  2015-12-18

6.  Effect of Polyethylene Cover for Preventing Corneal Injury in Critically Ill Patients: A Meta-Analysis.

Authors:  Tao Li; Huijuan Zhou
Journal:  Comput Math Methods Med       Date:  2022-01-28       Impact factor: 2.238

7.  Ocular surface disorders in intensive care unit patients.

Authors:  Tuba Berra Saritas; Banu Bozkurt; Baris Simsek; Zeynep Cakmak; Mehmet Ozdemir; Alper Yosunkaya
Journal:  ScientificWorldJournal       Date:  2013-10-29

8.  Incidence, risk factors and impact of protocolised care on exposure keratopathy in critically ill adults: a two-phase prospective cohort study.

Authors:  Obaid Kousha; Zubaid Kousha; Jonathan Paddle
Journal:  Crit Care       Date:  2018-01-16       Impact factor: 9.097

9.  Frontalis Sling Using a Silicone Rod for Ptosis in Third Nerve Palsy: Cosmesis versus Safety.

Authors:  Yong Min Choi; Namju Kim
Journal:  Korean J Ophthalmol       Date:  2022-01-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.